🧭Clinical Trial Compass

Am I eligible?Pricing About

Clinical Trial Compass

Data sourced from ClinicalTrials.gov and OpenFDA. For informational purposes only. Always consult your healthcare provider.

Not medical advice.

Citicoline in Youth Alcohol Use Disorder (NCT05870111) | Clinical Trial Compass

Active — Not RecruitingPhase 2

Citicoline in Youth Alcohol Use Disorder

United States56 participantsStarted 2024-10-01

Plain-language summary

The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.

Who can participate

Age range16 Years – 22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: Age 16 to 22. Call study team for additional screening and information.

What they're measuring

1

Peripheral Cytokine: IL-1B

Timeframe: 4 weeks of treatment

2

Peripheral Cytokine: IL-6

Timeframe: 4 weeks of treatment

3

Peripheral Cytokine: TNFα

Timeframe: 4 weeks of treatment

4

Brain Metabolite: N-acetyl-aspartate

Timeframe: 4 weeks of treatment

5

Brain Metabolite: Choline

Timeframe: 4 weeks of treatment

6

Neurocognition: Behavioral impulsivity

Timeframe: 4 weeks of treatment

7

Neurocognition: Cognitive Flexibility and Attention

Timeframe: 4 weeks of treatment

8

Neurocognition: Inhibitory Control and Attention

Timeframe: 4 weeks of treatment

Trial details

NCT IDNCT05870111

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-29

View on ClinicalTrials.gov More Alcohol Use Disorder trials